Fujian Wanchen Biotechnology Group Co., Ltd. (SHE: 300972)

Fujian Wanchen Biotechnology Group Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	14,050	5,807	1,848	2,433	-	-
Market Cap Growth	30.38%	214.22%	-24.04%	-	-	-
Enterprise Value	13,596	6,441	1,865	2,437	-	-
Last Close Price	78.06	37.54	12.04	15.60	-	-
PE Ratio	235.76	-	38.72	103.75	-	-
PS Ratio	0.51	0.62	3.36	5.60	-	-
PB Ratio	15.35	8.35	2.75	3.73	-	-
P/TBV Ratio	8.61	9.93	3.00	4.06	-	-
P/FCF Ratio	7.52	7.22	-	42.50	-	-
P/OCF Ratio	3.57	5.68	26.26	24.62	-	-
EV/Sales Ratio	0.54	0.69	3.39	5.61	-	-
EV/EBITDA Ratio	15.98	154.22	20.73	32.97	-	-
EV/EBIT Ratio	20.98	-	62.69	192.16	-	-
EV/FCF Ratio	7.28	8.01	-	42.57	-	-
Debt / Equity Ratio	1.31	1.64	0.47	0.15	0.45	0.64
Debt / EBITDA Ratio	1.83	8.40	3.32	1.28	1.13	1.35
Debt / FCF Ratio	0.83	1.42	-	1.66	1.79	1.61
Asset Turnover	5.56	3.63	0.53	0.57	0.68	0.64
Inventory Turnover	19.24	20.25	5.94	7.38	7.04	7.55
Quick Ratio	0.52	0.52	0.40	1.36	0.17	0.15
Current Ratio	1.07	0.89	0.84	1.67	0.44	0.36
Return on Equity (ROE)	36.70%	-21.35%	6.27%	4.45%	25.79%	27.19%
Return on Assets (ROA)	9.01%	-1.13%	1.80%	1.04%	9.46%	9.33%
Return on Capital (ROIC)	18.75%	-2.05%	2.15%	1.19%	10.84%	10.87%
Earnings Yield	0.42%	-1.43%	2.58%	0.96%	-	-
FCF Yield	13.30%	13.85%	-13.31%	2.35%	-	-
Dividend Yield	0.00%	-	-	1.41%	-	-
Payout Ratio	52.36%	-	82.15%	22.32%	50.99%	102.71%
Buyback Yield / Dilution	-13.53%	0.92%	-10.29%	-22.92%	0.69%	-0.10%
Total Shareholder Return	-13.53%	0.92%	-10.29%	-21.51%	0.69%	-0.10%

Source: S&P Capital IQ. Standard template. Financial Sources.